Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study
Article in International Journal of Clinical Oncology (May 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in International Journal of Clinical Oncology (May 2024)
Article in Critical Reviews in Oncology/Hematology (January 2022)
Book chapter (October 2021)